A Study of the ILB-3101 in Patients with Advanced Solid Tumors

NCT06426680 · clinicaltrials.gov ↗
PHASE1
Phase
RECRUITING
Status
240
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Innolake Biopharm